Market Research Logo

Radiopharmaceuticals: Technologies and Global Markets

Radiopharmaceuticals: Technologies and Global Markets

The global market radiopharmaceuticals were valued at nearly $5.1 billion and $5.7 billion in 2014 and 2015, respectively. This market is expected to increase from nearly $6.5 billion in 2016 to $11.6 billion in 2021 at a compound annual growth rate (CAGR) of 12.4% for 2016-2021.

This report provides:
An overview of the global market for radiopharmaceuticals and related technologies.
Analyses of global market trends, with data from 2014 and 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
Information on how radiopharmaceuticals are used to diagnose cancer, tumors, brain diseases, bone diseases, bone marrow diseases, colorectal disease, kidney diseases, liver diseases, lung diseases, and many others.
Details concerning the regulatory environment and the impacts of government on the market.
Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities
Profiles of leading companies in the industry.


SCOPE OF THE STUDY

This report focuses on the global market for radiopharmaceutical products. Radiopharmaceuticals provide actual mapping of the physiological functions and metabolic activity of organs. They provide highly specific information on organ function and dysfunction. Radiopharmaceuticals can also be used in radiotherapy to destroy dysfunctional cells.

In this report, BCC Research analyzes each global market in terms of applications, regulatory environment, new products and advancements, market projections and market shares. The geographical regions covered in the report are North America and Europe and an emerging markets category. The emerging markets category covers countries that include India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand and Canada.

This report also includes an analysis of relevant patent and comprehensive profiles of leading companies in the radiopharmaceuticals industry. Some of the major global players in the radiopharmaceuticals industry are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Bayer AG (Bayer HealthCare Pharmaceuticals Inc.), Bracco S.p.A. (Bracco Imaging S.p.A.), Cardinal Health Inc., Eli Lilly and Co., Fujifilm RI Pharma Co. Ltd. (Fujifilm Corp.), General Electric Co. (GE Healthcare), Jubilant Life Sciences (Jubilant DraxImage Inc.), Lantheus Holdings Inc. (Lantheus Medical Imaging Inc.), Mallinckrodt PLC, Navidea Biopharmaceuticals Inc., Noridon Inc., Piramal Enterprises Ltd. (Piramal Imaging SA), Siemens AG (Siemens PETNET Solutions Inc.) and Triad Isotopes Inc.

CHAPTER 1 INTRODUCTION
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ANALYSTS' CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL MARKET FOR RADIOPHARMACEUTICALS, BY REGION, THROUGH 2021 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET FOR RADIOPHARMACEUTICALS, BY REGION, 2014-2021 ($ MILLIONS)
CHAPTER 3 OVERVIEW
USES OF RADIOPHARMACEUTICALS
DIAGNOSTIC IMAGING
IN VIVO FUNCTION
IN VITRO STUDIES
THERAPEUTIC APPLICATIONS
DEFINITIONS
NUCLIDE
ISOTOPE
RADIATION
RADIOACTIVITY
ALPHA PARTICLES
BETA PARTICLES
GAMMA RAY
RADIOACTIVE DECAY
ISOMERIC TRANSITION
RADIOISOTOPE
RADIOPHARMACEUTICAL PRECURSOR
SPECIFIC ACTIVITY
LINEAR ENERGY TRANSFER
NEGATRON
POSITRON
TRANSMUTATION
HALF-LIFE
NUCLEAR MEDICINE
RADIOPHARMACY
PHARMACOKINETICS
MYELOSUPPRESSION
CRITICAL ORGAN
HISTORY AND BACKGROUND
TABLE 1 MILESTONES OF THE DISCOVERY OF RADIOACTIVITY AND NUCLEAR MEDICINE
ORIGIN OF RADIONUCLIDES
TYPES OF RADIONUCLIDES
Primordial Radionuclides
Secondary Radionuclides
Cosmogenic Radionuclides
METHODS OF PRODUCING RADIONUCLIDES
Nuclear Fission
Charged-particle Bombardment
Neutron Activation
Radionuclide Generator Systems
RADIONUCLIDES BY PRODUCTION TYPE
Particle Accelerator-Produced Radionuclides
Linear Particle Accelerators
Circular Particle Accelerators
TABLE 2 COMMON CYCLOTRON-PRODUCED
RADIONUCLIDES/RADIOISOTOPES
Nuclear Reactor-Produced Radionuclides
TABLE 3 COMMON NUCLEAR REACTOR-PRODUCED
RADIONUCLIDES/RADIOISOTOPES
RADIONUCLIDE GENERATORS
TABLE 4 COMMON RADIONUCLIDE PAIRS IN RADIONUCLIDE GENERATORS
COMMONLY USED RADIONUCLIDES IN MEDICINE
TECHNETIUM-99M
IODINE-123
IODINE-131
FLUORINE-18
INDIUM-111
THALLIUM-201
GALLIUM-67
PREPARATION OF RADIOPHARMACEUTICALS
RADIOPHARMACEUTICAL PREPARATION KITS
APPLICATIONS OF RADIOPHARMACEUTICALS
DIAGNOSTIC RADIOPHARMACEUTICALS
TABLE 5 COMMON ISOTOPES USED IN DIAGNOSTIC
RADIOPHARMACEUTICAL DEVELOPMENT
TABLE 6 SELECTED COMMERCIALLY APPROVED DIAGNOSTIC
RADIOPHARMACEUTICALS
TYPES OF DIAGNOSTIC RADIOPHARMACEUTICALS
PET Radiopharmaceuticals
SPECT Radiopharmaceuticals
THERAPEUTIC RADIOPHARMACEUTICALS
TABLE 7 COMMON ISOTOPSES USED IN THERAPEUTIC
RADIOPHARMACEUTICAL DEVELOPMENT
Radioimmunotherapy
TABLE 8 SELECTED COMMERCIALLY APPROVED THERAPEUTIC
RADIOPHARMACEUTICALS
Alpha Emitters
TAT/Alpha-immunotherapy
TABLE 9 ADVANTAGES AND DISADVANTAGES OF ALPHA EMITTERS
Beta Emitters
TABLE 10 ADVANTAGES AND DISADVANTAGES OF BETA EMITTERS
Brachytherapy
TABLE 11 COMMONLY USED RADIONUCLIDES (RADIATION SOURCES)
FOR BRACHYTHERAPY
TABLE 12 ADVANTAGES AND DISADVANTAGES OF BRACHYTHERAPY
THERANOSTIC AGENTS
ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS
TABLE 13 ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS
CHAPTER 4 REGULATORY ASPECTS
NEW DRUG APPROVALS AND APPLICATIONS
INVESTIGATIONAL NEW DRUG
NEW DRUG APPLICATION
TABLE 14 APPROVALS OF NEW DRUG APPLICATIONS FOR RADIOPHARMACEUTICALS, FROM JANUARY 2014 TO MAY 2016
ABBREVIATED NEW DRUG APPLICATION
TABLE 15 APPROVALS OF ABBREVIATED NEW DRUG APPLICATIONS FOR RADIOPHARMACEUTICALS, FROM JANUARY 2014 TO MAY 2016
APPROVALS FOR RADIONUCLIDE BRACHYTHERAPY SOURCES
PREMARKET APPROVAL
PREMARKET NOTIFICATION 510(K)
TABLE 16 510K APPROVALS FOR RADIONUCLIDE BRACHYTHERAPY SOURCES, JANUARY 2014-MAY 2016
SAFETY ALERTS
TABLE 17 SAFETY ALERTS ISSUED FOR RADIOPHARMACEUTICALS, FROM JANUARY 2014-MAY 2016
ADVERSE EVENT REPORTING
TABLE 18 ADVERSE EVENT REPORTING FOR RADIONUCLIDE
BRACHYTHERAPY SOURCES, FROM JANUARY 2014-MAY 2016
DRUG SHORTAGES
TABLE 19 RADIOPHARMACEUTICAL SHORTAGES, THROUGH MAY 2016
CHAPTER 5 NEW DEVELOPMENTS
PIPELINE PRODUCTS
TABLE 20 CLINICAL TRIALS FOR RADIOPHARMACEUTICALS, THROUGH MAY 2016
OTHER SIGNIFICANT NEW DEVELOPMENTS IN RADIOPHARMACEUTICALS
GALLIUM-68 PET/CT SCANS
CHAPTER 6 MARKET ANALYSIS
MARKET BY RADIOPHARMACEUTICAL TYPE
MARKET OVERVIEW
MARKET REVENUE
TABLE 21 GLOBAL MARKET FOR RADIOPHARMACEUTICALS, BY TYPE, THROUGH 2021 ($ MILLIONS)
FIGURE 1 GLOBAL MARKET FOR RADIOPHARMACEUTICALS, BY TYPE, 2014-2021 ($ MILLIONS)
MARKET SHARES
TABLE 22 GLOBAL MARKET SHARES OF RADIOPHARMACEUTICALS, BY TYPE, 2015 (%)
FIGURE 2 GLOBAL MARKET SHARES OF RADIOPHARMACEUTICALS, BY TYPE, 2015 (%)
DIAGNOSTIC RADIOPHARMACEUTICALS
Diagnostic Radiopharmaceuticals Market by Type of Diagnostic Test
Market Overview
Market Revenue
TABLE 23 GLOBAL MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS, BY TYPE OF DIAGNOSTIC TEST, THROUGH 2021 ($ MILLIONS)
FIGURE 3 GLOBAL MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS, BY TYPE OF DIAGNOSTIC TEST, 2014-2021 ($ MILLIONS)
PET Radiopharmaceuticals
PET Radiopharmaceuticals Market by Region
Revenue of PET Radiopharmaceuticals Market by Region
TABLE 24 GLOBAL MARKET FOR PET RADIOPHARMACEUTICALS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 4 GLOBAL MARKET FOR PET RADIOPHARMACEUTICALS, BY REGION, 2014-2021 ($ MILLIONS)
PET Radiopharmaceuticals Market by Type of Radionuclide
Revenue for PET Radiopharmaceuticals Market by Type of Radionuclide
TABLE 25 GLOBAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE OF RADIONUCLIDE, THROUGH 2021 ($ MILLIONS)
FIGURE 5 GLOBAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE OF RADIONUCLIDE, 2014-2021 ($ MILLIONS)
SPECT Radiopharmaceuticals
SPECT Radiopharmaceuticals Market by Region
Revenue of SPECT Radiopharmaceuticals Market by Region
TABLE 26 GLOBAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 6 GLOBAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY REGION, 2014-2021 ($ MILLIONS)
SPECT Radiopharmaceuticals Market by Type of Radionuclide
Revenue of SPECT Radiopharmaceuticals Market by Type of Radionuclide
TABLE 27 GLOBAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE OF RADIONUCLIDE, THROUGH 2021 ($ MILLIONS)
FIGURE 7 GLOBAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE OF RADIONUCLIDE, 2014-2021 ($ MILLIONS)
Other Diagnostic Radiopharmaceuticals
Other Diagnostic Radiopharmaceuticals Market by Region
Revenue of Other Diagnostic Radiopharmaceuticals Market by Region
TABLE 28 GLOBAL MARKET FOR OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 8 GLOBAL MARKET FOR OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2014-2021 ($ MILLIONS)
Other Diagnostic Radiopharmaceuticals Market by Type of Radionuclide
Revenue of Other Diagnostic Radiopharmaceuticals Market by Type of Radionuclide
TABLE 29 GLOBAL MARKET FOR OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, BY TYPE OF RADIONUCLIDE, THROUGH 2021 ($ MILLIONS)
FIGURE 9 GLOBAL MARKET FOR OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, BY TYPE OF RADIONUCLIDE, 2014-2021 ($ MILLIONS)
Market Share of Diagnostics Radiopharmaceutical by Type
TABLE 30 MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS, BY TYPE OF DIAGNOSTIC TEST, 2015 (%)
FIGURE 10 MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS, BY TYPE OF DIAGNOSTIC TEST, 2015 (%)
THERAPEUTIC RADIOPHARMACEUTICALS
Therapeutic Radiopharmaceuticals by Type
Market Overview
Market Revenue
TABLE 31 GLOBAL MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS, BY TYPE, THROUGH 2021 ($ MILLIONS)
FIGURE 11 GLOBAL MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS, BY TYPE, 2014-2021 ($ MILLIONS)
Alpha Emitters
Alpha Emitters Market by Region
Revenue of Alpha Emitters Market by Region
TABLE 32 GLOBAL MARKET FOR ALPHA EMITTERS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 12 GLOBAL MARKET FOR ALPHA EMITTERS, BY REGION, 2014-2021 ($ MILLIONS)
Alpha Emitters Market by Type of Radionuclide
Revenue of Alpha Emitters Market by Type of Radionuclide
TABLE 33 GLOBAL MARKET FOR ALPHA EMITTERS, BY TYPE OF RADIONUCLIDE, THROUGH 2021 ($ MILLIONS)
FIGURE 13 GLOBAL MARKET FOR ALPHA EMITTERS, BY TYPE OF RADIONUCLIDE, 2014-2021 ($ MILLIONS)
Beta Emitters
Beta Emitters Market by Region
Revenue of Beta Emitters Market by Region
TABLE 34 GLOBAL MARKET FOR BETA EMITTERS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 14 GLOBAL MARKET FOR BETA EMITTERS, BY REGION, 2014-2021 ($ MILLIONS)
Beta Emitters Market by Type of Radionuclide
Revenue of Beta Emitters Market by Type of Radionuclide
TABLE 35 GLOBAL MARKET FOR BETA EMITTERS, BY TYPE OF RADIONUCLIDE, THROUGH 2021 ($ MILLIONS)
FIGURE 15 GLOBAL MARKET FOR BETA EMITTERS, BY TYPE OF RADIONUCLIDE, 2014-2021 ($ MILLIONS)
Brachytherapy Seeds
LDR Brachytherapy Seeds Market by Region
Revenue of LDR Brachytherapy Seeds Market by Region
TABLE 36 GLOBAL MARKET FOR LDR BRACHYTHERAPY SEEDS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 16 GLOBAL MARKET FOR LDR BRACHYTHERAPY SEEDS, BY REGION, 2014-2021 ($ MILLIONS)
Brachytherapy Seeds Market by Type of Radionuclide
Revenue of Brachytherapy Seeds Market by Type of Radionuclide
TABLE 37 GLOBAL MARKET FOR BRACHYTHERAPY SEEDS, BY TYPE OF RADIONUCLIDE, THROUGH 2021 ($ MILLIONS)
FIGURE 17 GLOBAL MARKET FOR BRACHYTHERAPY SEEDS, BY TYPE OF RADIONUCLIDE, 2014-2021 ($ MILLIONS)
Market Shares of Therapeutic Radiopharmaceuticals by Type
TABLE 38 MARKET SHARES OF THERAPEUTIC RADIOPHARMACEUTICALS, BY TYPE, 2015 (%)
FIGURE 18 MARKET SHARES OF THERAPEUTIC RADIOPHARMACEUTICALS, BY TYPE, 2015 (%)
DIAGNOSTIC RADIOPHARMACEUTICALS MARKET BY REGION
MARKET OVERVIEW
MARKET REVENUE
TABLE 39 GLOBAL MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 19 GLOBAL MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2014-2021 ($ MILLIONS)
MARKET SHARES
TABLE 40 MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2015 (%)
FIGURE 20 MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2015 (%)
THERAPEUTIC RADIOPHARMACEUTICALS MARKET BY REGION
MARKET OVERVIEW
MARKET REVENUE
TABLE 41 GLOBAL MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 21 GLOBAL MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS, BY REGION, 2014-2021 ($ MILLIONS)
MARKET SHARES
TABLE 42 MARKET SHARES OF THERAPEUTIC RADIOPHARMACEUTICALS, BY REGION, 2015 (%)
FIGURE 22 MARKET SHARES OF THERAPEUTIC RADIOPHARMACEUTICALS, BY REGION, 2015 (%)
RADIOPHARMACEUTICALS MARKET BY PRODUCTION METHOD PARTICLE ACCELERATORS (CYCLOTRONS)
NUCLEAR REACTORS
RADIONUCLIDE GENERATORS
MARKET OVERVIEW
MARKET REVENUE
TABLE 43 GLOBAL MARKET FOR RADIOPHARMACEUTICALS, BY PRODUCTION METHOD, THROUGH 2021 ($ MILLIONS)
FIGURE 23 GLOBAL MARKET FOR RADIOPHARMACEUTICALS, BY PRODUCTION METHOD, 2014-2021 ($ MILLIONS)
MARKET SHARES
TABLE 44 MARKET SHARES OF RADIOPHARMACEUTICALS, BY PRODUCTION METHOD, 2015 (%)
FIGURE 24 MARKET SHARES OF RADIOPHARMACEUTICALS, BY PRODUCTION METHOD, 2015 (%)
CHAPTER 7 INDUSTRY STRUCTURE
DIAGNOSTIC RADIOPHARMACEUTICALS
PET RADIOPHARMACEUTICALS
Market Leaders
TABLE 45 LEADING MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2015
Market Shares
TABLE 46 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2015 (%)
FIGURE 25 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2015 (%)
SPECT RADIOPHARMACEUTICALS
Market Leaders
TABLE 47 LEADING MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2015
Market Shares
TABLE 48 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2015 (%)
FIGURE 26 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2015 (%)
OTHER DIAGNOSTIC RADIOPHARMACEUTICALS
Market Leaders
TABLE 49 LEADING MANUFACTURERS/SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2015
Market Shares
TABLE 50 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2015 (%)
FIGURE 27 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2015 (%)
THERAPEUTIC RADIOPHARMACEUTICALS
MARKET LEADERS
TABLE 51 LEADING MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2015
MARKET SHARES
TABLE 52 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2015 (%)
FIGURE 28 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2015 (%)
CHAPTER 8 PATENT ANALYSIS
PATENTS BY YEAR
TABLE 53 NUMBER OF SIGNIFICANT PATENTS FOR
RADIOPHARMACEUTICALS/ RADIONUCLIDES,
JANUARY 2014-MAY 2016
FIGURE 29 NUMBER OF SIGNIFICANT PATENTS FOR
RADIOPHARMACAUTICALS/ RADIONUCLIDES, FROM
JANUARY 2014-MAY 2016
PATENTS BY TYPE OF RADIONUCLIDE
TABLE 54 PATENTS BY TYPE OF RADIONUCLIDE, JANUARY 2014-MAY 2016
FIGURE 30 PATENTS BY TYPE OF RADIONUCLIDE, JANUARY 2014-MAY 2016
PATENTS BY COMPANY
TABLE 55 NUMBER OF PATENTS BY COMPANY, JANUARY 2014-MAY 2016
PATENTS BY COUNTRY
TABLE 56 NUMBER OF PATENTS BY COUNTRY, JANUARY 2014-MAY 2016
FIGURE 31 NUMBER OF PATENTS BY COUNTRY, JANUARY 2014-MAY 2016
TABLE 57 PATENT SHARES BY COUNTRY, JANUARY 2014-MAY 2016 (%)
FIGURE 32 PATENT SHARES BY COUNTRY, JANUARY 2014-MAY 2016 (%)
PATENTS BY ASSIGNEE TYPE
TABLE 58 NUMBER OF PATENTS BY ASSIGNEE TYPE, JANUARY 2014 -MAY 2016
FIGURE 33 NUMBER OF PATENTS BY ASSIGNEE TYPE, JANUARY 2014-MAY 2016
CHAPTER 9 CURRENT SITUATION
FACTORS AFFECTING THE RADIOPHARMACEUTICALS MARKET
DRIVERS OF THE RADIOPHARMACEUTICALS MARKET
Aging Population
Increasing Incidence of Life-threatening Diseases
Growing Focus on Early Diagnosis and Treatment
Launch of New Radiopharmaceuticals and Widening Applications
Growing Healthcare Spending in Emerging Regions
Increasing Number of Cyclotrons
Increasing Amount of Nuclear Imaging Equipment
Technological Advancements
RESTRAINTS AND CHALLENGES OF THE MARKET
Limited Global Supply of Medical Isotopes
Reimbursement Policies
Healthcare Reforms and Budgetary Constraints in Developed Countries
Regulatory Issues
COLLABORATIONS, MERGERS AND ACQUISITIONS
CHAPTER 10 COMPANY PROFILES
ACTINIUM PHARMACEUTICALS INC.
ADVANCED ACCELERATOR APPLICATIONS SA
ADVANCED MEDICAL ISOTOPE CORP.
ALLIANCE MEDICAL GROUP
ALSERES PHARMACEUTICALS INC.
AUSTRALIAN NUCLEAR ASSOCIATION AND TECHNOLOGY ORGANIZATION
AYTU BIOSCIENCE INC.
BARD MEDICAL
BAYER PHARMA AG
BLUE EARTH DIAGNOSTICS LTD.
BOARD OF RADIATION AND ISOTOPE TECHNOLOGY
BRACCO DIAGNOSTIC INC.
BTG INTERNATIONAL LTD.
CARDINAL HEALTH INC.
ELI LILLY AND COMPANY
FUJIFILM RI PHARMA CO. LTD.
GE HEALTHCARE
IBA MOLECULAR
ISORAY MEDICAL INC.
ISO-TEX DIAGNOSTICS INC.
JUBILANT DRAXIMAGE INC.
LANTHEUS MEDICAL IMAGING INC.
MALLINCKRODT PLC
NATIONAL CENTRE FOR NUCLEAR RESEARCH POLATOM
NATIONAL INSTITUTE FOR RADIOELEMENTS (IRE)
NAVIDEA BIOPHARMACEUTICALS INC.
NORDION INC.
NTP RADIOISOTOPES SOC LTD
PHARMALUCENCE INC.
PIRAMAL IMAGING SA
SIEMENS HEALTHCARE GMBH
SPECTRUM PHARMACEUTICALS INC.
TRIAD ISOTOPES INC.
ZEVACOR MOLECULAR
CHAPTER 11 ABBREVIATIONS
TABLE 59 ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report